UNITED THERAPEUTICS Corp

UTHR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001108501-26-000001
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: KURZWEIL RAY (Director)
SEC Filing link

Summary

Type

Sell

Net shares

-4,910

% of shares

-27.93%

Amount (USD)

$2,401,088

Insider confidence score

17.5 out of 100

Negative

  • Large discretionary sell (≥1% of shares)
  • Very large sell amount ($1M+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-04

Code

M

Net shares

+4,910.0

Price per Share

$101.80

Amount (USD)

$499,838.00

Acquired/Disposed

Acquired

Shares Owned Before

12,670.0

Shares Owned After

17,580.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-4,910.0

Price per Share

$489.02

Amount (USD)

$2,401,088.20

Acquired/Disposed

Disposed

Shares Owned Before

17,580.0

Shares Owned After

12,670.0

Derivative Transactions ⓘ

Transaction 1

Security

Stock Option

Action

Exercise

Date

2026-03-04

Code

M

Net shares

-4,910.0

Acquired/Disposed

Disposed

Shares Owned Before

4,910.0

Shares Owned After

0.0

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.